We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAL icon
7126
AGF US Market Neutral Anti-Beta Fund
BTAL
$307M
$24K ﹤0.01%
1,404
-1,642
-54% -$27.8K
CARR icon
7127
PUT
Carrier Global
CARR
$52.7B
$24K ﹤0.01%
+500
New +$22.3K
CVRX icon
7128
CVRx
CVRX
$158M
$24K ﹤0.01%
+859
New +$24.1K
ESQ icon
7129
Esquire Financial Holdings
ESQ
$1.14B
$24K ﹤0.01%
1,025
-1,551
-60% -$36.8K
EVOK
7130
DELISTED
Evoke Pharma
EVOK
$24K ﹤0.01%
120
-101
-46% -$21.6K
EZGO
7131
EZGO Technologies
EZGO
$2.31M
0
FDVV icon
7132
Fidelity High Dividend ETF
FDVV
$10.3B
$24K ﹤0.01%
+644
New +$24.1K
FPH icon
7133
Five Point Holdings
FPH
$370M
$24K ﹤0.01%
+2,940
New +$22.3K
GEF.B icon
7134
Greif Class B
GEF.B
$4.21B
$24K ﹤0.01%
400
-1,574
-80% -$94.8K
CBIO
7135
Crescent Biopharma
CBIO
$610M
$24K ﹤0.01%
103
-172
-63% -$43.8K
IMNM icon
7136
Immunome
IMNM
$2.92B
$24K ﹤0.01%
1,370
+922
+206% +$20.4K
IMOS
7137
ChipMOS TECHNOLOGIES
IMOS
$1.83B
$24K ﹤0.01%
702
-346
-33% -$11.4K
PHAT icon
7138
Phathom Pharmaceuticals
PHAT
$679M
$24K ﹤0.01%
699
-2,178
-76% -$78K
QAT icon
7139
iShares MSCI Qatar ETF
QAT
$63.8M
$24K ﹤0.01%
1,247
-885
-42% -$17.1K
QIPT
7140
DELISTED
Quipt Home Medical
QIPT
$24K ﹤0.01%
+3,750
New +$23K
QMOM icon
7141
Alpha Architect US Quantitative Momentum ETF
QMOM
$434M
$24K ﹤0.01%
+464
New +$23.4K
RNAC icon
7142
Cartesian Therapeutics
RNAC
$257M
$24K ﹤0.01%
191
-9,736
-98% -$1.16M
SCC icon
7143
ProShares UltraShort Consumer Discretionary
SCC
$6.51M
$24K ﹤0.01%
629
+136
+28% +$5.42K
TMF icon
7144
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.16B
$24K ﹤0.01%
90
-25
-22% -$6K
TPHD icon
7145
Timothy Plan High Dividend Stock ETF
TPHD
$363M
$24K ﹤0.01%
793
-2,263
-74% -$68K
TURN
7146
DELISTED
180 Degree Capital
TURN
$24K ﹤0.01%
3,000
-654
-18% -$5.05K
VABK icon
7147
Virginia National Bankshares
VABK
$254M
$24K ﹤0.01%
+608
New +$20.6K
VTVT icon
7148
vTv Therapeutics
VTVT
$136M
$24K ﹤0.01%
265
+167
+170% +$16.9K
WBIG icon
7149
WBI BullBear Yield 3000 ETF
WBIG
$31.7M
$24K ﹤0.01%
895
-1,059
-54% -$28K
WYY icon
7150
WidePoint Corp
WYY
$106M
$24K ﹤0.01%
+3,269
New +$25.7K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.